Nova Eye Medical (AU:EYE) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Nova Eye Medical Limited has announced the issuance of 300,000 performance rights as part of its employee incentive scheme, a move that may interest investors tracking unquoted equity developments. These unquoted securities are not intended for public trading on the ASX, reflecting the company’s strategy to reward and motivate its workforce internally.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.